• Nano-Code: 2020-1-BG01-KA226-HE-095017
Partnership Area
What are you looking for?

Nanotechnology vs. COVID-19: social, ethical and legal aspects

Since SARS-CoV-2 is a lipid-enveloped virus, only lipid-based formulations may be used for encapsulation of viral components.

Nanobiosensors offer accuracy and rapidity in diagnosing COVID-19.

Graphene-based biosensors are valuable for detection of all except:

“Nanoethics” is a new subfield of

When the EU has started to address the potential use of nanotechnologies?

Electrochemical nanobiosensors are the most widely used.

The biggest problem with regulating nanomedicines is the fact that regulatory agencies such as the FDA use safety data based on bulk materials that do not have the same pharmacodynamic and pharmacokinetic activity as nanomedicines?

Is it easy to do the regulation of activities in the field of nanotechnology?

In the nanoparticle-based detection color changes when virus is absent.

Nanoethics has the function

Leave a Reply